Cannabis Dispensaries
Is a Cannabis M&A Tidal Wave on the Way?

Is a Cannabis M&A Tidal Wave on the Way?


Is a Cannabis M&A Tidal Wave on the Way?

At the end of the month (March 30, 2026), shareholders of one of the fastest growing Canadian licenced producers, Organigram Global, will convene to decide the fate of its proposed €250m acquisition of Sanity Group

The deal, announced in February, marks the largest bet on Europe’s largest medical cannabis market by a North American operator to date, and signals a bullish outlook on the European opportunity more widely. 

While perhaps the most significant, certainly from the European perspective, it is by no means the only major M&A deal to have been announced over the last few months. 

Just this week, German pharmaceutical cannabis company Canify AG and African medical cannabis cultivator MG Health Limited announced plans to merge. Canify’s announcement came just days after Tilray announced its $40m acquisition of craft beer giant Brewdog. 

These examples are just the tip of the iceberg. Since September 2025, over a dozen further significant M&A deals have been announced across the globe. 

.boc-feature-card{
display:flex;
max-width:900px;
margin:40px auto;
border:1px solid #e6e6e6;
border-radius:10px;
overflow:hidden;
text-decoration:none;
color:#000;
font-family:Arial,Helvetica,sans-serif;
background:#fff;
transition:transform .25s ease, box-shadow .25s ease;
}

.boc-feature-card:hover{
transform:translateY(-3px);
box-shadow:0 14px 30px rgba(0,0,0,.10);
}

.boc-feature-card img{
width:45%;
object-fit:cover;
}

.boc-feature-content{
padding:26px;
display:flex;
flex-direction:column;
justify-content:center;
}

.boc-feature-kicker{
font-size:12px;
text-transform:uppercase;
letter-spacing:.06em;
color:#888;
margin-bottom:8px;
}

.boc-feature-title{
font-size:24px;
line-height:1.35;
margin:0 0 12px 0;
}

.boc-feature-excerpt{
font-size:15px;
color:#555;
line-height:1.6;
margin-bottom:16px;
}

.boc-feature-meta{
font-size:13px;
color:#999;
}

.boc-readmore{
margin-top:10px;
font-size:14px;
color:#3360FF;
font-weight:600;
}

.boc-feature-card:hover .boc-readmore{
text-decoration:underline;
}

/* mobile */
@media (max-width:700px){

.boc-feature-card{
flex-direction:column;
}

.boc-feature-card img{
width:100%;
height:auto;
}

.boc-feature-title{
font-size:20px;
}

}

Cannabis M&A Tracker

Business Intelligence

Cannabis M&A Tracker

A continuously updated dataset tracking mergers, acquisitions and major deals shaping the global cannabis industry since 2020.

Business of Cannabis Intelligence
Explore tracker →

With this in mind, it seems hard to argue that the long-touted ‘tidal wave’ of cannabis M&A deals is not now upon us.

But, as Mitchell Osak, strategist, consultant, and author of the Cannabis Management Review, argues, with thousands of companies operating across a fragmented global cannabis industry, ‘inevitably some M&A is happening’.

In his view, for this to represent a genuine wave, ‘lots of big, strategic deals that meaningfully influence sector revenue, market structures and the participant business performance’, must take place. 

Writing in a lengthy analysis circulated privately earlier this year, seen by Business of Cannabis, Osak argues that the industry is not yet financially or structurally healthy enough for that bar to be met. Balance sheets are too stretched, Schedule III too widely misunderstood, and the macro environment too precarious for anything resembling a tidal wave in 2026.

Yet not everyone agrees with that assessment. Veteran cannabis investor Seth Yakatan argues that the industry may already be in the early stages of a consolidation cycle. The mistake, he suggests, is expecting the next wave of cannabis M&A to resemble the headline-driven mergers that have defined other industries.

Click through to page 2 to read Mitchell Osak’s arguments in detail.

The post Is a Cannabis M&A Tidal Wave on the Way? appeared first on Business of Cannabis.

Source link

Got the munchies